Kaya HoldingsKAYS +0.02% Market Cap is $14.24 Mil as of Jun. 28, 2026. The stock has 4 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Kaya Holdings ranks worse than 82.01% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kaya Holdings's share price for the quarter that ended in Sep. 2025 was $0.04837. Kaya Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 686.43 Mil. Therefore, Kaya Holdings's market cap for the quarter that ended in Sep. 2025 was $33.20 Mil.
Kaya Holdings's quarterly market cap
declined
from Mar. 2025 ($1.66 Mil) to Jun. 2025 ($1.52 Mil) but then
increased
from Jun. 2025 ($1.52 Mil) to Sep. 2025 ($33.20 Mil).
Kaya Holdings's annual market cap
declined
from Dec. 2022 ($1.52 Mil) to Dec. 2023 ($0.93 Mil) but then
increased
from Dec. 2023 ($0.93 Mil) to Dec. 2024 ($1.16 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kaya Holdings's Enterprise Value for Today is $12.62 Mil.
Kaya Holdings (OTCPK:KAYS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kaya Holdings Market Cap Related Terms
Kaya Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Kaya Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kaya Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kaya Holdings Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kaya Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Kaya Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Kaya Holdings's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kaya Holdings (KAYS) has a Market Cap of $14.24 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kaya Holdings and its competitors. According to the industry distribution chart, Kaya Holdings ranks #839 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 82%.
Is Kaya Holdings' Market Cap too high?
Kaya Holdings' current Market Cap is $14.24 Mil. The Drug Manufacturers industry median Market Cap is 205.37. Kaya Holdings' value of $14.24 Mil is 93.1% below this industry median. Based on the distribution chart, Kaya Holdings ranks #839 out of 1023 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Kaya Holdings' Market Cap compare to TXMD and AYTU?
According to the Drug Manufacturers industry distribution chart, Kaya Holdings ranks #839 out of 1023 companies for Market Cap. This places Kaya Holdings in the lower half of its industry. The industry median Market Cap is 205.37. Kaya Holdings' value of $14.24 Mil is 93.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kaya Holdings's current Market Cap of $14.24 Mil is 93.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Kaya Holdings and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kaya Holdings's current Market Cap is $14.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaya Holdings stock overvalued right now?
Kaya Holdings (KAYS) has a current Market Cap of $14.24 Mil. The current Market Cap is $14.24 Mil and 93.1% below the Drug Manufacturers industry median of 205.37. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Kaya Holdings (KAYS), the current Market Cap is $14.24 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kaya Holdings Inc is a holding company. It is focusing on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company own and operate a medical cannabis dispensary in the United States. Its has produced, distributed, and/or sold a full range of premium cannabis products including flower, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting distinctive brands.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAYS has been successfully added to your 